Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.

Priora R, Margaritis A, Frosali S, Coppo L, Summa D, Di Giuseppe D, Aldinucci C, Pessina G, Di Stefano A, Di Simplicio P.

Pharmacol Res. 2011 Sep;64(3):289-97. doi: 10.1016/j.phrs.2011.03.014. Epub 2011 Apr 23.

PMID:
21539916
2.

Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.

Gordge MP, Hothersall JS, Noronha-Dutra AA.

Br J Pharmacol. 1998 May;124(1):141-8.

3.

Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Negrescu EV, Grünberg B, Kratzer MA, Lorenz R, Siess W.

Cardiovasc Drugs Ther. 1995 Aug;9(4):619-29.

PMID:
8547213
4.

Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.

Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL.

Biochem Biophys Res Commun. 2000 Dec 20;279(2):412-9.

PMID:
11118301
5.
7.

Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.

Irwin C, Roberts W, Naseem KM.

Platelets. 2009 Nov;20(7):478-86. doi: 10.3109/09537100903159375.

PMID:
19852686
9.

Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.

Fisch A, Michael-Hepp J, Meyer J, Darius H.

Eur J Pharmacol. 1995 May 26;289(3):455-61.

PMID:
7556414
10.

Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.

Marcondes S, Cardoso MH, Morganti RP, Thomazzi SM, Lilla S, Murad F, De Nucci G, Antunes E.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3434-9. Epub 2006 Feb 21.

11.

Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.

Gudmundsdóttir IJ, McRobbie SJ, Robinson SD, Newby DE, Megson IL.

Biochem Biophys Res Commun. 2005 Nov 11;337(1):382-5.

PMID:
16185664
12.

Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro.

Machtens S, Ckert S, Stief CG, Tsikas D, Frlich Jr, Jonas U.

Urology. 2003 Feb;61(2):479-83.

PMID:
12597985
13.
14.
15.

Inactivation of platelet glycoprotein IIb/IIIa receptor by nitric oxide donor 3-morpholino-sydnonimine.

Keh D, Thieme A, Kürer I, Falke KJ, Gerlach H.

Blood Coagul Fibrinolysis. 2003 Jun;14(4):327-34.

PMID:
12945873
16.

cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.

Paolocci N, Ekelund UE, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA, Hare JM.

Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1982-8.

17.

Inhibition of platelet adhesion to collagen by cGMP-elevating agents.

Wu CC, Ko FN, Teng CM.

Biochem Biophys Res Commun. 1997 Feb 13;231(2):412-6.

PMID:
9070290
18.
19.

[Effect of nitric oxide on the cryopreservation of platelets].

Lee JH, Kim JT, Cho YG.

Korean J Lab Med. 2008 Apr;28(2):136-43. doi: 10.3343/kjlm.2008.28.2.136. Korean.

Items per page

Supplemental Content

Write to the Help Desk